Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- Check10 days agoChange DetectedMinor UI and metadata updates were made: the glossary is now shown, the page revision was updated to v3.4.0, and QC/FEAR Act data labels were added or adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's Locations section has been updated to include numerous new sites across the United States and international locations (Australia, Canada, Japan, and others). The geographic coverage of listed study sites appears expanded.SummaryDifference2%

- Check68 days agoChange DetectedRevision: v3.3.2 is now shown on the page, updating from v3.3.1 to reflect a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedThe government funding status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.